Syneos Health Appoints Two New Independent Directors

NEXT STORY
Eldorado Provides 2022 Production and Cost Guidance and Outlines Improved Five-Year Outlook
PREV STORY
Global Respiratory Care Devices Markets, 2021-2026 with COVID-19 Impacts Analysis
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Onconova Enrolls First Patient in Phase 3 INSPIRE Trial of Rigosertib

NEWTOWN, Pa., Dec. 07, 2015 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a clinical-stage ...

author_avatar
NASDAQ Market News

Medivir focuses exclusively on oncology and reorganizes to significantly reduce the cost structure

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces a reorganization of the ...

author_avatar
NASDAQ Market News

Novartis announces landmark EU approval for one-time gene therapy Luxturna® to restore vision in people with rare inherited retinal disease

Luxturna* (voretigene neparvovec) is the first gene therapy to treat an inherited retinal disease, ...

author_avatar
NASDAQ Market News